{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T10:47:18Z","timestamp":1782211638346,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008967","name":"Philipps-Universit\u00e4t Marburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008967","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stereotactic radiotherapy (SRT) is a\u00a0standard treatment for vestibular schwannoma (VS). Long-term comparative data on single-fraction radiosurgery (SRS) versus normofractionated SRT (NFSRT) are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We retrospectively analyzed 175 VS patients treated between 1998 and 2023 (SRS\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u200969; NFSRT\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u2009106; median age\u00a061\u00a0years; median follow-up 46\u00a0months). Tumor control was evaluated with Kaplan\u2013Meier and Cox regression. Group differences were tested with Mann\u2013Whitney\u00a0U and chi-square\/Fisher\u2019s exact tests. Symptom changes were assessed with McNemar tests, and binary logistic regression identified predictors of acute and late toxicity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Overall, in-field PFS was 94.3% and out-field was PFS was 99.4%. All 10\u00a0recurrences (median 58.5\u00a0months) occurred in NFSRT patients treated with 55.8\u201356\u202fGy. Higher total dose predicted recurrence (HR\u202f=\u20092.97;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.003). At baseline, 97.1% reported symptoms (hearing loss 86.9%, vertigo 48.0%, tinnitus 42.3%). After therapy, symptoms remained stable, except the incidence of headache, which increased from 14.3% to 22.3% (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.02). Early toxicities were more common after NFSRT, including headache (OR\u202f=\u20094.05;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.01), fatigue (OR\u202f=\u20095.12;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.01), and alopecia (OR\u202f=\u200919.9;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u20090.04), but had resolved by late follow-up. Age and prior surgery predicted vertigo patterns over time. Radionecrosis was rare (0.6%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Both SRS and NFSRT achieve excellent long-term tumor control with low severe toxicity. For NFSRT, normofractionated doses above 55\u202fGy did not improve efficacy and may increase the recurrence risk, supporting moderate-dose regimens (50\u201354\u202fGy). Symptom stabilization confirms the safety of SRT, though headache and vertigo remain relevant long-term issues. Careful dose selection, patient counseling, and rehabilitation are essential to optimize outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00066-026-02516-1","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:16:45Z","timestamp":1774610205000},"page":"751-759","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of different modalities of radiotherapy in vestibular schwannoma: tumor control, symptom evolution, and toxicity profiles"],"prefix":"10.1007","volume":"202","author":[{"given":"Phillipp","family":"Lishewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerem Tuna","family":"Tas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Frosan","family":"Sheikhzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Smalec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Agolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Nimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Kemmling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Habermehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemens","family":"Zink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5557-7438","authenticated-orcid":false,"given":"Ahmed","family":"Gawish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Adeberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"key":"2516_CR1","unstructured":"Louis DN. The 2021 WHO Classification of Tumors of the Central Nervous System: a\u00a0summary - PubMed [Internet]. [zitiert 20.\u00a0Februar 2026]. Verf\u00fcgbar unter: https:\/\/pubmed.ncbi.nlm.nih.gov\/34185076\/"},{"issue":"5","key":"2516_CR2","first-page":"690","volume":"21","author":"MF Howitz","year":"2000","unstructured":"Howitz\u00a0MF, Johansen\u00a0C, Tos\u00a0M, Charabi\u00a0S, Olsen\u00a0JH (2000) Incidence of vestibular schwannoma in Denmark, 1977\u20131995. Am J Otol 21(5):690\u2013694","journal-title":"Am J Otol"},{"issue":"2","key":"2516_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/01945998211042006","volume":"167","author":"JP Marinelli","year":"2022","unstructured":"Marinelli\u00a0JP, Beeler\u00a0CJ, Carlson\u00a0ML, Caye-Thomasen\u00a0P, Spear\u00a0SA, Erbele\u00a0ID (2022) Global Incidence of Sporadic Vestibular Schwannoma: A Systematic Review. Otolaryngol Neck Surg 167(2):209\u2013214. https:\/\/doi.org\/10.1177\/01945998211042006","journal-title":"Otolaryngol Neck Surg"},{"issue":"2","key":"2516_CR4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.otc.2011.12.008","volume":"45","author":"SE Stangerup","year":"2012","unstructured":"Stangerup\u00a0SE, Caye-Thomasen\u00a0P (2012) Epidemiology and natural history of vestibular schwannomas. Otolaryngol Clin North Am 45(2):257\u2013268. https:\/\/doi.org\/10.1016\/j.otc.2011.12.008","journal-title":"Otolaryngol Clin North Am"},{"issue":"1","key":"2516_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1227\/NEU.0000000000001414","volume":"80","author":"K M","year":"2017","unstructured":"M\u00a0K, K\u00a0K, S\u00a0H, T\u00a0D, SE\u00a0S, P\u00a0C\u2011T (2017) Ten-Year Follow-up on Tumor Growth and Hearing in Patients Observed With an Intracanalicular Vestibular Schwannoma. Neurosurgery 80(1):49\u201356. https:\/\/doi.org\/10.1227\/NEU.0000000000001414","journal-title":"Neurosurgery"},{"issue":"14","key":"2516_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1056\/NEJMra2020394","volume":"384","author":"ML Carlson","year":"2021","unstructured":"Carlson\u00a0ML, Link\u00a0MJ (2021) Vestibular Schwannomas. N\u00a0Engl J Med 384(14):1335\u20131348. https:\/\/doi.org\/10.1056\/NEJMra2020394","journal-title":"N Engl J Med"},{"issue":"1","key":"2516_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/neuonc\/noz153","volume":"22","author":"R Goldbrunner","year":"2020","unstructured":"Goldbrunner\u00a0R, Weller\u00a0M, Regis\u00a0J, Lund-Johansen\u00a0M, Stavrinou\u00a0P, Reuss\u00a0D et\u00a0al (2020) EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro-Oncol 22(1):31\u201345. https:\/\/doi.org\/10.1093\/neuonc\/noz153","journal-title":"Neuro-Oncol"},{"issue":"3","key":"2516_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3171\/2011.11.JNS11811","volume":"116","author":"BD Milligan","year":"2012","unstructured":"Milligan\u00a0BD, Pollock\u00a0BE, Foote\u00a0RL, Link\u00a0MJ (2012) Long-term tumor control and cranial nerve outcomes following \u03b3 knife surgery for larger-volume vestibular schwannomas. J\u00a0Neurosurg 116(3):598\u2013604. https:\/\/doi.org\/10.3171\/2011.11.JNS11811","journal-title":"J Neurosurg"},{"issue":"4","key":"2516_CR9","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.ijrobp.2010.10.010","volume":"79","author":"ES Murphy","year":"2011","unstructured":"Murphy\u00a0ES, Suh\u00a0JH (2011) Radiotherapy for vestibular schwannomas: a\u00a0critical review. Int J Radiat Oncol Biol Phys 79(4):985\u2013997. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.10.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2516_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ijrobp.2005.01.055","volume":"63","author":"SE Combs","year":"2005","unstructured":"Combs\u00a0SE, Volk\u00a0S, Schulz-Ertner\u00a0D, Huber\u00a0PE, Thilmann\u00a0C, Debus\u00a0J (2005) Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): long-term results in 106 patients treated in a\u00a0single institution. Int J Radiat Oncol Biol Phys 63(1):75\u201381. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.01.055","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2516_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/jns.2001.94.1.0001","volume":"94","author":"JC Flickinger","year":"2001","unstructured":"Flickinger\u00a0JC, Kondziolka\u00a0D, Niranjan\u00a0A, Lunsford\u00a0LD (2001) Results of acoustic neuroma radiosurgery: an analysis of 5\u00a0years\u2019 experience using current methods. J\u00a0Neurosurg 94(1):1\u20136. https:\/\/doi.org\/10.3171\/jns.2001.94.1.0001","journal-title":"J Neurosurg"},{"issue":"Suppl","key":"2516_CR12","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3171\/JNS\/2008\/109\/12\/S20","volume":"109","author":"ME Linskey","year":"2008","unstructured":"Linskey\u00a0ME (2008) Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters? J\u00a0Neurosurg 109(Suppl):129\u2013136. https:\/\/doi.org\/10.3171\/JNS\/2008\/109\/12\/S20","journal-title":"J Neurosurg"},{"issue":"5","key":"2516_CR13","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/s0360-3016(01)01559-0","volume":"50","author":"DW Andrews","year":"2001","unstructured":"Andrews\u00a0DW, Suarez\u00a0O, Goldman\u00a0HW, Downes\u00a0MB, Bednarz\u00a0G, Corn\u00a0BW et\u00a0al (2001) Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 50(5):1265\u20131278. https:\/\/doi.org\/10.1016\/s0360-3016(01)01559-0","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2516_CR14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","volume":"45","author":"EA Eisenhauer","year":"2009","unstructured":"Eisenhauer\u00a0EA, Therasse\u00a0P, Bogaerts\u00a0J, Schwartz\u00a0LH, Sargent\u00a0D, Ford\u00a0R et\u00a0al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version\u00a01.1). Eur J Cancer 45(2):228\u2013247. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"issue":"1","key":"2516_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.adro.2018.08.013","volume":"4","author":"KR Fega","year":"2019","unstructured":"Fega\u00a0KR, Fletcher\u00a0GP, Waddle\u00a0MR, Peterson\u00a0JL, Ashman\u00a0JB, Barrs\u00a0DM et\u00a0al (2019) Analysis of MRI Volumetric Changes After Hypofractionated Stereotactic Radiation Therapy for Benign Intracranial Neoplasms. Adv Radiat Oncol 4(1):43\u201349. https:\/\/doi.org\/10.1016\/j.adro.2018.08.013","journal-title":"Adv Radiat Oncol"},{"key":"2516_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctro.2021.12.003","volume":"33","author":"O Fouard","year":"2022","unstructured":"Fouard\u00a0O, Daisne\u00a0JF, Wanet\u00a0M, Regnier\u00a0M, Gustin\u00a0T (2022) Long-term volumetric analysis of vestibular schwannomas following stereotactic radiotherapy: Practical implications for follow-up. Clin Transl Radiat Oncol 33:1\u20136. https:\/\/doi.org\/10.1016\/j.ctro.2021.12.003","journal-title":"Clin Transl Radiat Oncol"},{"issue":"5","key":"2516_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051496","volume":"15","author":"D Rue\u00df","year":"2023","unstructured":"Rue\u00df\u00a0D, Sch\u00fctz\u00a0B, Celik\u00a0E, Baues\u00a0C, J\u00fcnger\u00a0ST, Neuschmelting\u00a0V et\u00a0al (2023) Pseudoprogression of Vestibular Schwannoma after Stereotactic Radiosurgery with Cyberknife\u00ae: Proposal for New Response Criteria. Cancers 15(5):1496. https:\/\/doi.org\/10.3390\/cancers15051496","journal-title":"Cancers"},{"issue":"7","key":"2516_CR18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2217\/fon.13.271","volume":"10","author":"AJ Walker","year":"2014","unstructured":"Walker\u00a0AJ, Ruzevick\u00a0J, Malayeri\u00a0AA, Rigamonti\u00a0D, Lim\u00a0M, Redmond\u00a0KJ et\u00a0al (2014) Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol Lond Engl 10(7):1277\u20131297. https:\/\/doi.org\/10.2217\/fon.13.271","journal-title":"Future Oncol Lond Engl"},{"key":"2516_CR19","unstructured":"(2024) Downloading IBM SPSS Statistics 29 [CT738,CT763,CT761,CT762] [Internet]. https:\/\/www.ibm.com\/support\/pages\/downloading-ibm-spss-statistics-29. Accessed 19.9.2024"},{"key":"2516_CR20","unstructured":"Prism - GraphPad [Internet]. [zitiert 23.\u00a0Juli 2025]. Verf\u00fcgbar unter: https:\/\/www.graphpad.com\/features"},{"issue":"4","key":"2516_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0090-3019(03)00025-9","volume":"59","author":"Y Iwai","year":"2003","unstructured":"Iwai\u00a0Y, Yamanaka\u00a0K, Ishiguro\u00a0T (2003) Surgery combined with radiosurgery of large acoustic neuromas. Surg Neurol 59(4):283\u2013289. https:\/\/doi.org\/10.1016\/s0090-3019(03)00025-9","journal-title":"Surg Neurol"},{"issue":"10","key":"2516_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzae085","volume":"104","author":"J Yap","year":"2024","unstructured":"Yap\u00a0J, Palmer\u00a0G, Graving\u00a0K, Stone\u00a0S, Gane\u00a0EM (2024) Vestibular Rehabilitation: Improving Symptomatic and Functional Outcomes of Persons With Vestibular Schwannoma: A Systematic Review. Phys Ther 104(10):pzae085. https:\/\/doi.org\/10.1093\/ptj\/pzae085","journal-title":"Phys Ther"},{"issue":"1","key":"2516_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10143-023-02214-x","volume":"46","author":"A Buben\u00edkov\u00e1","year":"2023","unstructured":"Buben\u00edkov\u00e1\u00a0A, Vlas\u00e1k\u00a0A, F\u00edk\u00a0Z, Sedl\u00e1k\u00a0V, Tesa\u0159ov\u00e1\u00a0M, Brad\u00e1\u010d\u00a0O (2023) Application of diffusion tensor imaging of the facial nerve in preoperative planning for large vestibular schwannoma: a systematic review. Neurosurg Rev 46(1):298\u2013298. https:\/\/doi.org\/10.1007\/s10143-023-02214-x","journal-title":"Neurosurg Rev"},{"issue":"8","key":"2516_CR24","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1002\/lary.20988","volume":"120","author":"BT Shaffer","year":"2010","unstructured":"Shaffer\u00a0BT, Cohen\u00a0MS, Bigelow\u00a0DC, Ruckenstein\u00a0MJ (2010) Validation of a disease-specific quality-of-life instrument for acoustic neuroma: the Penn Acoustic Neuroma Quality-of-Life Scale. The Laryngoscope 120(8):1646\u20131654. https:\/\/doi.org\/10.1002\/lary.20988","journal-title":"The Laryngoscope"},{"issue":"1","key":"2516_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/neuonc\/nou284","volume":"17","author":"D Kondziolka","year":"2015","unstructured":"Kondziolka\u00a0D, Shin\u00a0SM, Brunswick\u00a0A, Kim\u00a0I, Silverman\u00a0JS (2015) The biology of radiosurgery and its clinical applications for brain tumors. Neuro-Oncol 17(1):29\u201344. https:\/\/doi.org\/10.1093\/neuonc\/nou284","journal-title":"Neuro-Oncol"},{"key":"2516_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104745","volume":"155","author":"B Farhood","year":"2020","unstructured":"Farhood\u00a0B, Khodamoradi\u00a0E, Hoseini-Ghahfarokhi\u00a0M, Motevaseli\u00a0E, Mirtavoos-Mahyari\u00a0H, Eleojo Musa\u00a0A et\u00a0al (2020) TGF\u2011\u03b2 in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res 155:104745. https:\/\/doi.org\/10.1016\/j.phrs.2020.104745","journal-title":"Pharmacol Res"},{"key":"2516_CR27","doi-asserted-by":"publisher","unstructured":"Marchetti M, Pinzi V, Gemma M, Cuccarini V, Pascuzzo R, Cane I, Romeo A, Morlino S, De Martin E, Fariselli L. Hypofractionated Versus Single-Session Radiosurgery to Preserve Hearing in Patients Affected by Sporadic Vestibular Schwannoma: The ACOUNEU Randomized Clinical Trial. Int J Radiat Oncol Biol Phys. 2025 Sep 1;123(1):107-117. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.03.081. Epub 2025 Apr 11. PMID: 40222395.","DOI":"10.1016\/j.ijrobp.2025.03.081"},{"key":"2516_CR28","doi-asserted-by":"publisher","unstructured":"Gawish A, Walke M, R\u00f6llich B, Ochel HJ, Brunner TB. Vestibular Schwannoma Hypofractionated Stereotactic Radiation Therapy in Five Fractions. Clin Oncol (R Coll Radiol). 2023 Jan;35(1):e40-e47. https:\/\/doi.org\/10.1016\/j.clon.2022.10.014. Epub 2022 Nov 2. PMID: 36335041.","DOI":"10.1016\/j.clon.2022.10.014"},{"issue":"10475","key":"2516_CR29","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(24)02319-5","volume":"405","author":"II Verginadis","year":"2025","unstructured":"Verginadis\u00a0II, Citrin\u00a0DE, Ky\u00a0B, Feigenberg\u00a0SJ, Georgakilas\u00a0AG, Hill-Kayser\u00a0CE et\u00a0al (2025) Radiotherapy toxicities: mechanisms, management, and future directions. Lancet Lond Engl 405(10475):338\u2013352. https:\/\/doi.org\/10.1016\/S0140-6736(24)02319-5","journal-title":"Lancet Lond Engl"},{"issue":"5","key":"2516_CR30","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/s0360-3016(03)00444-9","volume":"56","author":"OWM Meijer","year":"2003","unstructured":"Meijer\u00a0OWM, Vandertop\u00a0WP, Baayen\u00a0JC, Slotman\u00a0BJ (2003) Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: a\u00a0single-institution study. Int J Radiat Oncol Biol Phys 56(5):1390\u20131396. https:\/\/doi.org\/10.1016\/s0360-3016(03)00444-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2516_CR31","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1016\/s0360-3016(00)01361-4","volume":"48","author":"M Fuss","year":"2000","unstructured":"Fuss\u00a0M, Debus\u00a0J, Lohr\u00a0F, Huber\u00a0P, Rhein\u00a0B, Engenhart-Cabillic\u00a0R et\u00a0al (2000) Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 48(5):1381\u20131387. https:\/\/doi.org\/10.1016\/s0360-3016(00)01361-4","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2516_CR32","doi-asserted-by":"publisher","first-page":"685","DOI":"10.3171\/jns.2003.99.4.0685","volume":"99","author":"Y Sawamura","year":"2003","unstructured":"Sawamura\u00a0Y, Shirato\u00a0H, Sakamoto\u00a0T, Aoyama\u00a0H, Suzuki\u00a0K, Onimaru\u00a0R et\u00a0al (2003) Management of vestibular schwannoma by fractionated stereotactic radiotherapy and associated cerebrospinal fluid malabsorption. J\u00a0Neurosurg 99(4):685\u2013692. https:\/\/doi.org\/10.3171\/jns.2003.99.4.0685","journal-title":"J Neurosurg"},{"issue":"1","key":"2516_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-018-1040-z","volume":"13","author":"CM van Leeuwen","year":"2018","unstructured":"van Leeuwen\u00a0CM, Oei\u00a0AL, Crezee\u00a0J, Bel\u00a0A, Franken\u00a0NAP, Stalpers\u00a0LJA et\u00a0al (2018) The alfa and beta of tumours: a\u00a0review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol 13(1):96. https:\/\/doi.org\/10.1186\/s13014-018-1040-z","journal-title":"Radiat Oncol"},{"issue":"5","key":"2516_CR34","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.3171\/jns.2002.97.5.1091","volume":"97","author":"J R\u00e9gis","year":"2002","unstructured":"R\u00e9gis\u00a0J, Pellet\u00a0W, Delsanti\u00a0C, Dufour\u00a0H, Roche\u00a0PH, Thomassin\u00a0JM et\u00a0al (2002) Functional outcome after gamma knife surgery or microsurgery for vestibular schwannomas. J\u00a0Neurosurg 97(5):1091\u20131100. https:\/\/doi.org\/10.3171\/jns.2002.97.5.1091","journal-title":"J Neurosurg"},{"issue":"1","key":"2516_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1055\/s-0032-1304559","volume":"73","author":"V Rinaldi","year":"2012","unstructured":"Rinaldi\u00a0V, Casale\u00a0M, Bressi\u00a0F, Potena\u00a0M, Vesperini\u00a0E, De Franco\u00a0A et\u00a0al (2012) Facial Nerve Outcome after Vestibular Schwannoma Surgery: Our Experience. J\u00a0Neurol Surg Part B Skull Base 73(1):21\u201327. https:\/\/doi.org\/10.1055\/s-0032-1304559","journal-title":"J Neurol Surg Part B Skull Base"},{"key":"2516_CR36","doi-asserted-by":"publisher","DOI":"10.1227\/NEU.0b013e3182752b05","volume":"72","author":"Y Nonaka","year":"2013","unstructured":"Nonaka\u00a0Y, Fukushima\u00a0T, Watanabe\u00a0K, Friedman\u00a0AH, Sampson\u00a0JH, Mcelveen\u00a0JTJ et\u00a0al (2013) Contemporary Surgical Management of Vestibular Schwannomas: Analysis of Complications and Lessons Learned Over the Past Decade. Oper Neurosurg 72:ons103. https:\/\/doi.org\/10.1227\/NEU.0b013e3182752b05","journal-title":"Oper Neurosurg"},{"key":"2516_CR37","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/315952","volume":"2014","author":"J Betka","year":"2014","unstructured":"Betka\u00a0J, Zv\u011b\u0159ina\u00a0E, Balogov\u00e1\u00a0Z, Profant\u00a0O, Sk\u0159ivan\u00a0J, Kraus\u00a0J et\u00a0al (2014) Complications of Microsurgery of Vestibular Schwannoma. BioMed Res Int 2014:315952. https:\/\/doi.org\/10.1155\/2014\/315952","journal-title":"BioMed Res Int"},{"issue":"4","key":"2516_CR38","doi-asserted-by":"publisher","first-page":"863","DOI":"10.3171\/2008.12.JNS08611","volume":"111","author":"H Kano","year":"2009","unstructured":"Kano\u00a0H, Kondziolka\u00a0D, Khan\u00a0A, Flickinger\u00a0JC, Lunsford\u00a0LD (2009) Predictors of hearing preservation after stereotactic radiosurgery for acoustic neuroma. J\u00a0Neurosurg 111(4):863\u2013873. https:\/\/doi.org\/10.3171\/2008.12.JNS08611","journal-title":"J Neurosurg"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-026-02516-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-026-02516-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:56:26Z","timestamp":1782208586000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-026-02516-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2516"],"URL":"https:\/\/doi.org\/10.1007\/s00066-026-02516-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.\u00a0Adeberg: honoraria\/travel reimbursement from Accuray Inc., AstraZeneca GmbH, Servier, Bristol Myers Squibb GmbH & Co., MSD, Novocure GmbH, Merck KGaA, Fakult\u00e4t Heidelberg, Fakult\u00e4t Marburg, Sanofi Genzyme; research cooperations with Novocure GmbH; scientific advisory function for Accuray Inc., Sanofi Genzyme, Servier, Novartis, Novocure GmbH, Merck KGaA. P.\u00a0Lishewski, M.\u00a0Fischer, K.T.\u00a0Tas, F.F.\u00a0Sheikhzadeh, E.\u00a0Smalec, L.\u00a0Agolli, C.\u00a0Nimsky, A.\u00a0Kemmling, D.\u00a0Habermehl, K.\u00a0Zink, and A.\u00a0Gawish declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the ethics committee of the Philipps University Marburg (nr.\u00a024-138-RS at 03.06.2024) and was carried out in accordance with the Declaration of Helsinki. The requirement for informed consent was waived because of the retrospective design.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}